logo
Plus   Neg
Share
Email

Bosch To Buy Siemens' 50% Stake In BSH JV For About EUR 3 Bln

Bosch and German conglomerate Siemens AG (SIEGY) agreed that Robert Bosch GmbH will acquire Siemens' 50 percent stake in the joint venture BSH Bosch und Siemens Hausgeräte GmbH or BSH. The purchase price will total 3 billion euros. In addition, Siemens and Bosch will each receive from BSH an additional distribution of 250 million euros before the transaction is completed.

The transaction has been approved by the Board of Management and Supervisory Board of Bosch and the Managing Board and Supervisory Board of Siemens.

The transaction, which still requires regulatory approval, will probably be completed in the first half of calendar year 2015. BSH will then become a wholly owned subsidiary of the Bosch Group.

As per the terms of the agreement, BSH will also be allowed to produce and market household appliances under the Siemens brand over the long term.

In 1967, Bosch and Siemens combined their activities in the area of household appliances to create the joint venture BSH.

On Sunday, US oilfield equipment maker Dresser-Rand Group Inc. (DRC) agreed to be acquired by German conglomerate Siemens for $83.00 per share in an all-cash deal valued at about $7.6 billion, including assumed debt.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
MillerCoors LLC has filed a lawsuit against Anheuser-Busch Companies LLC, part of Anheuser-Busch InBev, alleging that Anheuser-Busch's ad campaigns associating MillerCoors' products, Miller Lite and Coor Light, with corn syrup is "false and misleading." During the Super Bowl, ABInBev ran an advertising campaign that mocked Miller Lite and Coors Light use corn syrup in brewing. Shares of Biogen Inc. are falling almost 28 percent in Thursday's trading after the company and Japanese drugmaker Eisai Co. said they will discontinue two late-stage trials for their experimental Alzheimer's drug, Aducanumab. The two Phase 3 trials, ENGAGE and EMERGE, are multi-center, randomized, double-blind, placebo-controlled, parallel-group studies designed to evaluate Aducanumab. The European Union on Wednesday ordered Alphabet Inc.'s Google to pay an antitrust fine of 1.49 billion euros for abusing its dominant position in the online search advertising intermediation market by preventing competition. This is the third antitrust fine by the EU against Google and it represents 1.29 percent of the tech giant's turnover in 2018.
Follow RTT